Ready-to-use documents, not just explanations
Plug-and-play SOPs, policies, procedures, work instructions, protocols, forms, logs, checklists, and risk assessments. Each one carries the full inspection-grade structure with placeholders for your company, system, and process, plus a worked filled-in specimen. Copy it, fill it in, route it through your own document control.
SOP 5
- Process Validation →CPV Signal Response and Escalation SOP
A plug-and-play standard operating procedure governing what happens the moment a Continued Process Verification chart fires a rule: triage into single-point assessment or formal investigation, the assignable-cause search, and the change-control gate a control-limit recalculation must clear, with a filled specimen.
- Drug Product →In-Transit Shipment Monitoring and Alert Escalation SOP
A plug-and-play standard operating procedure for real-time, GPS-enabled cold chain shipment monitoring: setting watch and escalate alert thresholds with real margin, naming an escalation owner and backup with an acknowledgment time limit, and the tiered response each level is authorized to take, with a filled specimen.
- Tech Transfer & NPI →Person-in-Plant Program SOP
A plug-and-play standard operating procedure governing a sponsor's person-in-plant program at a contract manufacturer: control header, responsibilities, definitions, the observe-document-escalate-verify procedure, acceptance criteria, records, and a filled specimen.
- CDMO Governance →Post-Release Deviation Regulatory Reporting SOP
A plug-and-play standard operating procedure for classifying and filing a Biological Product Deviation Report or Field Alert Report when the triggering information originates at a contract manufacturer rather than inside the sponsor's own walls, with a decision table, a notification-clock worksheet, and a filled specimen.
- Tech Transfer & NPI →Virtual PIP Oversight Data Integrity SOP
A plug-and-play standard operating procedure for qualifying and operating a virtual or remote person-in-plant oversight setup: camera and feed qualification, read-only electronic batch record access, audit trail requirements, and a defined feed-interruption response, with a filled specimen.
Protocol 14
- Tech Transfer & NPI →Analytical Method Transfer Protocol
A plug-and-play protocol for transferring an analytical method between a sending and receiving lab under USP <1224>: mechanism selection, acceptance criteria tied to method precision, sample plan, and disposition, with a filled specimen.
- Drug Product →CCIT Method Transfer and Bridging Study Protocol
A plug-and-play protocol for transferring a validated container closure integrity test method to a new or contract fill-finish site: receiving-instrument equipment qualification, a certified defect-standard bridging run compared against the sending site's result, fixture qualification, and a no-change-to-the-MALL acceptance basis, with a filled specimen.
- Drug Product →CCIT Study Protocol
A plug-and-play container closure integrity testing study protocol built on USP <1207>: method selection rationale, positive control strategy, a container-system-by-condition sample matrix, acceptance criteria, and lifecycle testing points, with a filled specimen.
- Drug Product →Cold Chain Shipping Qualification Protocol
A plug-and-play shipping qualification protocol for cryoshippers, dry ice, phase-change, and mechanically cooled shippers: worst-case lane design, seasonal and payload configuration testing, temperature mapping, acceptance criteria, dangerous goods classification confirmation, and report commitments, with a filled specimen.
- Drug Product →Cryoformulation Freeze-Thaw Study Protocol
A plug-and-play protocol for qualifying a cell or biologic product's cryoformulation and cooling profile against worst-case handling: cycle design, acceptance criteria beyond viability, sampling, deviation handling, and a filled specimen.
- Tech Transfer & NPI →Engineering Run Protocol and After-Action Review
A plug-and-play engineering run protocol with defined entry and exit criteria, plus a fixed-agenda after-action review that surfaces surprises before a validation batch does, with a filled specimen.
- Drug Product →Filter Sizing and Flux Decay Study Protocol
A plug-and-play protocol for sizing a sterilizing-grade filter from small-scale flux decay data: the model-fit check, the Vmax-style extrapolation, the safety margin, and the final filter-area selection, with a filled specimen.
- Drug Product →Forced Degradation / Stress Study Protocol
A plug-and-play protocol for designing a forced degradation study by modality, thermal, photostability, oxidative, pH, and mechanical stress conditions mapped to what actually degrades a protein, oligonucleotide, or viral vector, with acceptance criteria and a filled specimen.
- Drug Product →LNP Formulation Critical Process Parameter Qualification Protocol
A plug-and-play protocol for qualifying the mixing and buffer-exchange process parameters that set lipid nanoparticle particle size, encapsulation efficiency, and zeta potential, with a batch matrix, acceptance criteria, and a filled specimen.
- Process Validation →Master Cell Bank / Working Cell Bank Qualification Protocol
A plug-and-play protocol for qualifying a master cell bank and deriving a working cell bank for an allogeneic cell therapy program: donor eligibility linkage, ICH Q5D characterization testing, identity by short tandem repeat profiling, genetic and karyotypic stability, tumorigenicity risk for an iPSC-derived line, acceptance criteria, and a filled specimen.
- Process Validation →PPQ Protocol Skeleton
A plug-and-play process performance qualification protocol skeleton: prerequisites checklist, batch matrix, CPP and CQA acceptance criteria tables, sampling plan, in-PPQ deviation handling, data analysis plan, and report commitments, with a filled specimen.
- Drug Product →Pre-Flush (Pre-Saturation) Validation Protocol
A plug-and-play protocol for sizing and validating a sterilizing-filter pre-flush that saturates membrane binding sites ahead of a low-concentration or surfactant-controlled biologic, with a filled specimen.
- Drug Product →Sterilizing Filter Validation Protocol
A plug-and-play sterilizing-grade filter validation protocol: bacterial retention study design against worst-case process parameters, bacteriostasis screening, physical integrity test correlation, and acceptance criteria, with a filled specimen.
- Drug Product →Vent and Gas Filter Validation Protocol
A plug-and-play validation protocol for a hydrophobic vent or gas filter on a bioreactor, hold tank, or lyophilizer: the gas-phase retention basis, the water intrusion integrity test, and the sterilization cycle-life study that sets a defensible replacement interval, with a filled specimen.
Plan 12
- Drug Product →CCIT Result Investigation and Artifact Decision Plan
A plug-and-play plan for agreeing, before a real CCIT failure happens, the pre-authorized sequence for ruling an artifact in or out before a borderline or failing result is treated as a true leak, with a conservative default for genuine ambiguity and a filled specimen.
- CDMO Governance →CDMO Technical Due Diligence Plan
A plug-and-play plan for running a CDMO technical assessment before signing: scope, approach, risk basis, deliverables, roles and schedule, acceptance criteria, and the handoff into the technical agreement, with a filled specimen.
- Process Validation →Continued Process Verification (CPV) Plan
A plug-and-play continued process verification plan: parameter selection rationale, data sources, statistical methods, review cadence, escalation triggers, roles, and the APR/PQR linkage, with a filled specimen.
- Process Validation →CPV Multivariate Monitoring Plan
A plug-and-play plan for operationalizing multivariate Continued Process Verification monitoring: training set qualification, model build and validation, ongoing operation, and the change-control gate a retraining must clear, with a filled specimen.
- Drug Product →Formulation Development Plan
A plug-and-play plan for running formulation development end to end: stage-gated excipient screening tied to the modality's actual failure mode, the liquid-versus-lyophilized presentation decision, freeze-thaw and high-concentration readiness linkage, and a filled specimen.
- Drug Product →International Shipment Customs and Import Contingency Plan
A plug-and-play contingency plan for an international cold chain lane: named broker contacts, pre-staged import documentation, coolant rescue options, and the specific decision point for treating a long customs hold as a probable excursion, with a filled specimen.
- Tech Transfer & NPI →Person-in-Plant Oversight Plan
A plug-and-play plan for a sponsor's person-in-plant program at a contract manufacturer: scope, on-site/virtual/hybrid model selection by risk, roles, escalation channel, and a filled specimen for a CAR-T fill campaign.
- Process Validation →PPQ Deviation Criticality Pre-Classification Plan
A plug-and-play plan for agreeing, before PPQ batch one, what class a deviation during the campaign falls into and what that class does to batch disposition and the concurrent-release hold trigger, with worked classification criteria and a filled specimen.
- Drug Product →Redundant (Serial) Filtration Validation Plan
A plug-and-play validation plan for two sterilizing-grade filters run in series, forcing each position onto its own bacterial retention and integrity test record and stating the combined-system versus independent sterility claim, with a filled specimen.
- Process Validation →Single-Source and Long-Lead Raw Material Contingency Plan
A plug-and-play plan for inventorying single-source and long-lead raw materials feeding a PPQ campaign, comparing replacement lead time against actual schedule margin, and naming the triggered contingency for each, with a filled specimen.
- Tech Transfer & NPI →Technology Transfer Plan
A plug-and-play technology transfer plan covering sending and receiving site scope, the transfer team and RACI, document deliverables, process and analytical transfer linkage, engineering run strategy, and timeline gates, with a filled specimen.
- Process Validation →Validation Master Plan
A plug-and-play Validation Master Plan for a clinical-stage or commercial biotech: scope by GxP impact, phase-appropriate rigor, a dual FDA/EU-PIC/S lifecycle map, roles, periodic review triggers, and a filled specimen.
Risk Assessment 21
- Process Validation →ALCOA+ Data Integrity Risk Assessment Worksheet
A plug-and-play worksheet scoring a GxP system or record-keeping process against each ALCOA+ element, attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available, so a data integrity risk assessment states a specific basis for every element instead of a generic compliance assertion, with a filled specimen contrasting an electronic batch record system against a paper logbook.
- Drug Product →CCIT Change Control and Revalidation Trigger Assessment
A plug-and-play risk assessment for deciding, at every stopper, crimp, supplier, lyophilization cycle, packaging, or shipping-lane change, whether an existing CCIT validation package still applies or needs re-verification, with a filled specimen.
- Drug Product →CCIT Method Selection and MALL Risk Assessment
A plug-and-play risk assessment for choosing a container closure integrity test method and deriving its maximum allowable leakage limit (MALL): the three-question USP <1207.1> selection logic, a scored method-fit register, MALL derivation, and a filled specimen.
- Drug Product →CCIT Sampling Strategy and Batch-Size Tier Justification
A plug-and-play risk assessment tiering a container closure integrity testing sampling strategy by batch population size, from a commercial AQL-sampled lot down to a one-unit autologous batch with no retest capacity, with a filled specimen.
- CDMO Governance →CDMO Critical Starting Material and Raw Material Sourcing Risk Assessment
A plug-and-play risk assessment for the starting materials a CDMO's process depends on, plasmid DNA, viral seed stock, cell banks, and specialized media, scoring single-source exposure and characterization gaps before they become a program schedule risk, with a filled specimen.
- CDMO Governance →CDMO Exit Readiness, Dual-Sourcing, and IP and Data Ownership Assessment
A plug-and-play risk assessment for whether a program could actually leave a CDMO relationship with what it needs, tech transfer package completeness, data and IP ownership at termination, and dual-source readiness, scored before signature, with a filled specimen.
- CDMO Governance →CDMO Financial Health and Business Continuity Risk Assessment
A plug-and-play risk assessment for a dimension a technical and quality audit routinely misses, whether the CDMO or its parent is financially stable enough to still be running your process in two or three years, with scoring, a 506C regulatory cross-check, and a filled specimen.
- CDMO Governance →CDMO Fourth-Party and Sub-Tier Supplier Risk Assessment
A plug-and-play risk assessment for the CDMO's own suppliers, single-use component and resin manufacturers, outsourced testing and calibration providers, and critical equipment service vendors, distinct from biological starting-material sourcing, with scoring and a filled specimen.
- CDMO Governance →CDMO GMO Containment and Biosafety Risk Assessment
A plug-and-play risk assessment for confirming a viral vector or other GMO-based CDMO's containment classification, institutional biosafety review, and segregation posture fit the specific process and scale, with a filled specimen.
- Drug Product →Delivery Platform Selection Risk Assessment: LNP vs. GalNAc Conjugate
A plug-and-play FMEA-style risk assessment for choosing between LNP delivery and GalNAc-conjugate delivery for an oligonucleotide program: scoring scales, a platform-comparison assessment table, mitigations, residual risk, and a filled specimen.
- Drug Product →Filter Extractables and Leachables Risk Assessment
A plug-and-play risk assessment mapping a filter manufacturer's generic extractables data onto the real product contact time, temperature, and chemistry, and deciding whether a product-specific leachables study is warranted, with a filled specimen.
- Drug Product →Filter Material Compatibility and Non-Specific Adsorption Risk Assessment
A plug-and-play risk assessment for evaluating whether a sterilizing-grade filter membrane will adsorb protein, polysorbate, or another formulation component, and for sizing a validated pre-flush where warranted, with a filled specimen.
- Drug Product →Filter Validation Revalidation Impact Assessment
A plug-and-play risk assessment for deciding, at every process, formulation, or filter-manufacturer change, whether an existing sterilizing filter validation package still applies or needs a new bacterial retention study, integrity test correlation, or bracketing review, with a filled specimen.
- Drug Product →Formulation Modality Stress Risk Assessment
A plug-and-play FMEA-style risk assessment for formulation development: scoring scales, a stress-by-modality assessment table tied to the actual degradation mechanism, mitigations, residual risk, and a filled specimen.
- Process Validation →Legacy and Acquired Product Validation Package Adequacy Assessment
A plug-and-play assessment for deciding, system by system, whether an inherited validation package from an acquired or in-licensed product meets the acquiring company's own GxP-impact risk tiers, accept as-is, supplement, or revalidate, grounded in ICH Q7's narrow retrospective validation exception, with a filled specimen covering an acquired AAV gene therapy asset.
- Regulatory CMC →PPQ Batch Count and Release Strategy Risk-Based Justification
A plug-and-play risk assessment for justifying a PPQ batch count below the traditional three-lot norm under a phase-appropriate or FDA CMC flexibility approach: a severity/occurrence/detectability risk register, mitigation actions, and residual risk acceptance, with a filled specimen.
- Process Validation →Provisional Control Limit Justification for Low-Volume CPV
A plug-and-play risk assessment justifying provisional control limits or a qualitative trend review in place of a fully powered control chart for a clinical-stage or low-volume commercial CPV program, with a filled specimen.
- Drug Product →PUPSIT Risk-Based Justification
A plug-and-play risk assessment justifying whether pre-use, post-sterilization integrity testing is performed or risk-based omitted, addressing flaw-masking probability, post-use test strength, and compensating engineering controls, with a filled specimen.
- Drug Product →Shipping Lane Risk Assessment
A plug-and-play risk assessment for deciding whether a new or changed cold chain shipping lane needs its own dedicated qualification run or can be bracketed under an already-qualified worse-case lane: scoring methodology, the assessment table, mitigations, and a filled specimen.
- Tech Transfer & NPI →Single-Use System and Raw Material Equivalency Assessment
A plug-and-play risk assessment for the three quiet equivalency traps a technology transfer risk register often misses: raw material sourcing, single-use component substitution, and automation recipe migration, with scoring, a bridging/verification plan, and a filled specimen.
- Tech Transfer & NPI →Technology Transfer Risk Assessment
A plug-and-play risk assessment for a technology transfer: a severity/occurrence/detectability risk register by process step, facility-fit and equipment differences, scale effects, mitigation owners, and residual risk acceptance, with a filled specimen.
Matrix 16
- Regulatory CMC →CMC Filing Data-Source Classification Matrix
A plug-and-play matrix classifying every data point cited in S.2.5, P.3.5, S.2.6, and P.2 as characterization, release, or PPQ evidence, and checking each against the scale it was generated at, so a filing never cites scaled-down or characterization-stage data toward a claim only commercial-scale release or PPQ data can support, with a filled specimen.
- Process Validation →Computerized System GAMP 5 Category and Risk-Tier Crosswalk Worksheet
A plug-and-play worksheet crosswalking a computerized system's GAMP 5 category against the VMP's own GxP-impact risk tier, so validation depth is set by both what the system is and what a failure in it would cost, not by either one alone, with a filled specimen.
- Process Validation →CPV Parameter Selection and Traceability Matrix
A plug-and-play matrix tracing every Continued Process Verification parameter back to its Stage 1 criticality source, with chart type, control limit basis, and review frequency in one view, with a filled specimen.
- Process Validation →Cross-Modality Regulatory Framework and Inspection-Readiness Matrix
A plug-and-play reference matrix mapping the marketing pathway, primary regulation, and modality-specific inspection risk for small molecule, medical device, RNAi or oligonucleotide, cell therapy, gene therapy, and RNA editing products, with a filled specimen.
- CDMO Governance →Deviation Severity and Impact Taxonomy Crosswalk
A plug-and-play matrix mapping a sponsor's own deviation severity taxonomy against each CDMO partner's local classification scheme, catching folded-together tiers before a real event does, with a filled specimen.
- Drug Product →Filter Bracketing (Matrix) Validation Justification
A plug-and-play matrix justifying a bracketed filter validation approach across a portfolio of related formulations: the bracketed physicochemical parameters, the worst-case member tested, and the equivalence rationale for every other member, with a filled specimen.
- CDMO Governance →Network Change Control Master Record
A plug-and-play traceability matrix for tracking one change across every CDMO site it touches, with a per-site assessment table, a closure checklist, and a filled specimen showing an excipient change that would have shipped mismatched without it.
- CDMO Governance →Network Process-Step Duplication Map
A plug-and-play live record of which process step runs at which CDMO site, which products or equipment trains overlap, and when each entry was last verified, so an impact assessment or a change control review can check a shared exposure in minutes, with a filled specimen.
- Tech Transfer & NPI →PIP Portfolio Coverage Prioritization Matrix
A plug-and-play matrix for ranking concurrent CDMO campaigns against a limited pool of qualified PIPs, so coverage decisions are risk-ranked and documented rather than assigned by availability, with a filled specimen.
- Regulatory CMC →Post-Approval Change Submission Vehicle Matrix
A plug-and-play matrix for classifying a manufacturing, facility, or control change against the FDA Prior Approval Supplement / CBE-30 / Annual Report tiers and the EU Type II / Type IB / Type IA variation tiers, before the change reaches the floor, with a filled specimen.
- Process Validation →Potency Assurance Triangulation Matrix
A plug-and-play matrix mapping a gene or cell therapy product's complementary potency measures, transduction or expression readout, functional bioassay, molecular measure, against the biological claim each one supports, so the potency strategy rests on a panel rather than a single imperfect assay, with a filled specimen.
- Regulatory CMC →QOS-to-Module-3 Validation Traceability Matrix
A plug-and-play matrix tracing every validation claim in the Quality Overall Summary's 2.3.S.2.5 and 2.3.P.3.5 back to its full support in Module 3, so the summary never asserts more, or less, than the detailed section actually proves, with a filled specimen.
- CDMO Governance →Quality Agreement Gap Assessment
A plug-and-play element-by-element comparison of a live CDMO quality agreement against FDA's recommended elements and the EU GMP Chapter 7 no-silent-subcontracting rule, with a filled specimen showing a missing major-deviation notification clock.
- Process Validation →Sponsor-CDMO VMP Scope Boundary Matrix
A plug-and-play matrix for a virtual or CDMO-dependent biotech to state, system by system, which GxP-relevant activity is governed by the sponsor's own Validation Master Plan and which is governed by the CDMO's, tracing each line to the quality agreement clause that assigns it, with a filled specimen.
- Tech Transfer & NPI →Technology Transfer Gap Assessment
A plug-and-play, factual side-by-side comparison of sending-site and receiving-site facility, equipment, utilities, personnel qualification, and quality systems, each row closed with a stated disposition, feeding the transfer risk assessment, with a filled specimen.
- Process Validation →Validation Risk Classification Matrix
A plug-and-play GxP-impact risk tiering matrix for scoping a Validation Master Plan: methodology, scoring criteria, the assessment table, and a filled specimen distinguishing a Tier 1 computerized system from an out-of-scope tool.
Checklist 17
- Tech Transfer & NPI →Automation and Control System Migration Verification Checklist
A plug-and-play checklist for verifying a migrated automation or control system recipe before an engineering run: migration method documentation, independent logic review, interlock and alarm parity, historian tag mapping, and a dry-run/FAT exercising every condition, with a filled specimen.
- CDMO Governance →CDMO Regulatory Standing and Inspection History Check
A plug-and-play checklist for independently verifying a CDMO's FDA and EU inspection history, rather than relying on the CDMO's own summary, with classification meanings and a filled specimen.
- CDMO Governance →CDMO Technical Assessment Scorecard
A plug-and-play scorecard for assessing a contract development and manufacturing organization: scored sections for capability, capacity, quality systems, data systems, analytical, transfer track record, and culture, a scoring rubric, a red-flag list, and a decision summary, with a filled specimen.
- Tech Transfer & NPI →CDMO-to-CDMO Transfer Handoff Checklist
A plug-and-play checklist for the handoff items a second, commercial-stage transfer between contract manufacturers needs beyond the standard technology transfer plan: change-history reconciliation, CPV-trend comparability, contractual data rights, platform-experience verification, and the quality agreement amendment, with a filled specimen.
- Regulatory CMC →CMC and Validation Strategy Meeting Briefing Package Checklist
A plug-and-play checklist for preparing the CMC and process-validation content of an INTERACT, pre-IND, End-of-Phase 2, or pre-BLA meeting briefing package, so the validation strategy gets pressure-tested with FDA before it is written into a filing, with a filled specimen.
- Regulatory CMC →CMC Validation Summary Filing Readiness Checklist
A plug-and-play readiness checklist for the S.2.5 and P.3.5 process validation sections of an IND, BLA, or NDA: content completeness, consistency, PPQ batch-count rationale, disclosure discipline, and pre-approval inspection alignment, with a filled specimen.
- Process Validation →CPV Program Maturity Self-Assessment Checklist
A plug-and-play checklist that scores a Continued Process Verification program against four maturity levels, from charts that exist but go unread to a governed multivariate build, with a filled specimen.
- Process Validation →Cross-Modality Validation Transition Checklist
A plug-and-play checklist for a validation professional or program moving between modalities, small molecule, device, LNP or oligonucleotide, cell therapy, or gene therapy, to confirm what carries over and what has to be re-derived before assuming a control still holds, with a filled specimen.
- Drug Product →Cryoshipper Return and Reconditioning Checklist
A plug-and-play go/no-go checklist for a reusable cold chain shipper's return trip: dangerous goods status at return, decontamination, damage inspection, and the out-of-cycle verification triggers that decide whether a unit clears for its next charge, with a filled specimen.
- Drug Product →High-Concentration Prefilled Syringe Formulation Readiness Checklist
A plug-and-play checklist for moving a formulation from vial toward a high-concentration prefilled syringe: viscosity, fill and delivery systems, siliconization, analytical re-qualification, and container closure, with pass/fail/NA items and a filled specimen.
- CDMO Governance →Partner Investigation Adequacy Review Checklist
A plug-and-play checklist for grading a CDMO's root cause investigation before a sponsor accepts it: whether the causal chain terminates on something correctable, whether trend data was checked, and whether the CAPA addresses the control gap itself, with a filled specimen.
- Process Validation →PIC/S PI 006-4 Transition Checklist
A plug-and-play checklist for bringing a Validation Master Plan's references and scope current against PIC/S PI 006-4, in force 1 October 2026, replacing the four-document PI 006-3 structure with performance qualification, utility qualification, transport verification, and test method validation added to scope, with a filled specimen.
- Tech Transfer & NPI →PIP Campaign Readiness Checklist
A plug-and-play pre-campaign go/no-go checklist for a person-in-plant assignment: oversight model selection against the risk table, authority and access confirmed, escalation channel tested, PIP qualification verified, with a filled specimen.
- Tech Transfer & NPI →PIP Regulatory Inspection Support Checklist
A plug-and-play checklist defining a person-in-plant's authorized role, escalation contacts, and reporting duties if a health authority inspector arrives at the CDMO during an assignment, with a filled specimen.
- Process Validation →PPQ Readiness Review Checklist
A plug-and-play pre-execution checklist covering all thirteen PPQ readiness prerequisites, process characterization through CDMO slot logistics, personnel and training currency, raw material contingency, deviation criticality classification, protocol amendment procedure, and aseptic-process readiness for sterile products, each scored against dated documentary evidence rather than a verbal assurance, with a filled specimen.
- Tech Transfer & NPI →Technology Transfer Completion Readiness Checklist
A plug-and-play checklist that tests whether a technology transfer is actually done, not just technically executed, across process performance, analytical status, personnel independence, deviation trends, CAPA closure, documentation, and quality acceptance, with a filled specimen.
- Process Validation →VMP Periodic Review Checklist
A plug-and-play checklist for the periodic review of a Validation Master Plan: calendar-based and trigger-based items, pass/fail/NA fields, and a filled specimen showing a phase-change review pulled forward.
Form 10
- Tech Transfer & NPI →Bioreactor and Unit Operation Scale Translation Worksheet
A plug-and-play worksheet for identifying the engineering parameter that actually governs a process step, power per volume, tip speed, kLa, mixing time, linear velocity, or membrane loading, re-deriving it on the receiving site's equipment, and documenting the scale-down model qualification basis, with a filled specimen.
- Process Validation →CPV Control Limit Recalculation Justification
A plug-and-play form documenting the trigger, statistical basis, and approval for recalculating Continued Process Verification control limits, so a limit never moves quietly to make an inconvenient trend disappear, with a filled specimen.
- Drug Product →Filter Hold-Up Volume and Yield Loss Characterization Worksheet
A plug-and-play worksheet for measuring sterilizing-filter and downstream tubing hold-up volume and its yield impact, sized to programs where drug substance is scarce, with a filled sample row.
- Drug Product →Mean Kinetic Temperature Calculation Worksheet
A plug-and-play worksheet for calculating and retaining mean kinetic temperature for a cold chain temperature excursion: inputs, the kinetic-averaging method, a field-by-field calculation table, and a filled specimen with worked numbers.
- Tech Transfer & NPI →PIP Independence and Conflict of Interest Disclosure
A plug-and-play disclosure and screening form completed before a person-in-plant assignment: prior CDMO employment, personal and financial relationships, and reporting-line pressure, with a documented disqualify-or-manage decision and a filled specimen.
- Tech Transfer & NPI →PIP Visit and Trip Report
A plug-and-play person-in-plant visit report form: planned versus observed, deviations and events, open items with owners, trend notes, and a filled specimen showing a real line-clearance finding.
- Process Validation →PPQ Acceptance Criteria and Concurrent Release Basis
A plug-and-play decision record stating whether a PPQ protocol's acceptance criteria are the commercial release specification or a tighter provisional in-process limit, and whether the campaign will rely on concurrent release, with named hold triggers and a filled specimen.
- Process Validation →PPQ Protocol Amendment Justification Form
A plug-and-play form for deciding and documenting a mid-campaign PPQ protocol amendment as distinct from a deviation: the data behind the change, its effect on batches already run, and its effect on any concurrent-release strategy, with a filled specimen.
- Process Validation →Process Validation Approach Selection Worksheet
A plug-and-play worksheet for choosing traditional, continuous, or hybrid process validation using a fixed set of criteria, so the choice is consistent across processes and validation leads instead of re-argued protocol by protocol, with a filled specimen covering all three outcomes.
- Drug Product →Vein-to-Vein Time and Temperature Budget Worksheet
A plug-and-play worksheet for mapping every stage between apheresis collection and infusion against its qualified maximum duration and temperature range, so a delay at any single stage is visible against the cumulative budget before it becomes a missed window, with a filled specimen.
Log 17
- Regulatory CMC →Anticipated Regulatory Questions Log
A plug-and-play log for capturing the questions a careful internal reviewer raises while S.2.5 and P.3.5 are still being drafted, answering them in the text before the agency has to ask, with a filled sample row.
- Drug Product →CCIT System Suitability Verification Log
A plug-and-play log for bracketing every CCIT test session with negative and positive controls at or near the MALL, with trending of the control margin between full revalidations, and a filled specimen.
- CDMO Governance →CDMO Deviation Notification and Cross-Network Impact Assessment Log
A plug-and-play log tracking every partner-site deviation from the original event through confirmed notification, root cause depth check, and cross-network impact assessment, so a deviation at one CDMO never quietly stays a single-site question, with a filled specimen.
- CDMO Governance →CDMO Escalation Pattern Log
A plug-and-play running log tracking every CDMO issue against the six-rung escalation ladder, so a claim that an issue is a pattern rather than an incident survives being checked instead of resting on one person's memory, with a filled specimen.
- CDMO Governance →CDMO Finding Disposition Register
A plug-and-play log for tracking every finding from a CDMO technical assessment through to closure: field definitions, disposition categories, retention, and a filled sample row, so no open item quietly becomes permanent.
- CDMO Governance →CDMO PPQ Slot Readiness Log
A plug-and-play running log for tracking the four CDMO logistics prerequisites, transfer closure, comparability, material release, and facility fit, against a booked PPQ manufacturing slot, so a slot-versus-readiness conflict surfaces with enough margin to act on it, with a filled specimen.
- Process Validation →Chain of Identity Verification Log
A plug-and-play log for verifying and recording a single patient's chain of identity through every handoff of an autologous cell therapy process, collection through courier dispatch, in-process manufacturing, and infusion, so an identity gap is caught at the handoff rather than discovered later in a record review, with a filled sample row.
- Process Validation →CPV Trend Signal Investigation and Escalation Log
A plug-and-play running log tracking every Continued Process Verification signal from the rule that fired through assessment, investigation, and closure, so a chart with a visible pattern and zero investigations never passes as a clean record, with a filled specimen.
- Drug Product →Cryoshipper Dispatch and Chain-of-Custody Log
A plug-and-play log for recording a cryoshipper's charge state, orientation check, logger assignment, dangerous goods documentation, and chain-of-custody events for every real patient-dose shipment, with a filled sample row.
- Drug Product →Cryoshipper Fleet Periodic Qualification and Vacuum Integrity Log
A plug-and-play running log for tracking every dry vapor shipper in a fleet against its periodic static evaporation rate verification, visual and functional inspection, cycle count, and any out-of-cycle trigger, with a filled sample row.
- Process Validation →GxP System and Process Inventory Register
A plug-and-play register listing every system and process a Validation Master Plan governs: GxP-impact category, risk tier, qualification status, and review dates, with a filled specimen showing a Tier 1 and a Tier 3 entry side by side.
- Tech Transfer & NPI →PIP Observation and CAPA Escalation Log
A plug-and-play running log tracking person-in-plant observations from escalation through verified closure, distinguishing closure as claimed from closure as verified, with a filled specimen.
- Tech Transfer & NPI →PIP Shift Handoff and Continuity Log
A plug-and-play handoff log transferring coverage between person-in-plant shifts on a multi-shift or round-the-clock campaign: batch status, open items, unlogged verbal commitments, and a signed confirmation of receipt, with a filled specimen.
- Regulatory CMC →Regulatory Information Request and List of Questions Response Log
A plug-and-play log for tracking FDA Information Requests and EMA Lists of Questions during a review cycle: question text, named discipline owner, deadline, response classification, sign-off, and clock impact, with a filled sample row.
- Drug Product →Routine Batch Filter Integrity Test Log
A plug-and-play running log for post-use and, where applicable, PUPSIT filter integrity test results across routine batches, with field definitions, a filled sample row, and retention guidance.
- Drug Product →Seal Quality (RSF / Torque) Monitoring Log
A plug-and-play in-line seal quality monitoring log under USP <1207.3>: residual seal force or removal/application torque readings tied back to a leak-tested acceptance range, with trending and an out-of-range escalation path, and a filled specimen.
- Tech Transfer & NPI →Tribal Knowledge Capture Log
A plug-and-play log for capturing undocumented operator and analyst knowledge during a technology transfer, through interviews, video review, or shadowing, with a disposition for each item, with a filled specimen.
Report 9
- CDMO Governance →CDMO Quality System Drift Scorecard
A plug-and-play quarterly report trending the seven metrics that reveal a contract manufacturer's quality system drifting before it produces a deviation serious enough to threaten a batch, with escalation-ladder linkage and a filled specimen.
- CDMO Governance →CDMO Technical Assessment Summary Report
A plug-and-play narrative report that converts a completed CDMO technical assessment, scorecard and disposition register, into a short, readable recommendation an executive sponsor can act on before signature, with a filled specimen.
- Process Validation →CPV Periodic Trend Summary Report
A plug-and-play periodic Continued Process Verification trend summary report, the document that sits between an individual control chart and the annual product review, with a parameter-by-parameter conclusion and a filled specimen.
- Drug Product →Formulation Development Report
A plug-and-play report summarizing a completed formulation development program: results against every stage gate, the presentation decision and its supporting data, deviations, conclusion, and handoff to tech transfer, with a filled specimen.
- Tech Transfer & NPI →PIP Program Metrics and Trend Scorecard
A plug-and-play quarterly rollup report measuring whether a person-in-plant program itself is working: visit turnaround, escalation-to-CAPA conversion, claimed-versus-verified closure rate, and coverage against the risk model, with a filled specimen.
- Regulatory CMC →PPQ Master Summary Table for Filing
A plug-and-play master summary table for process performance qualification results, one row per CQA or CPP and one column per batch, built for direct use in an S.2.5 or P.3.5 CTD section, with the opening paragraph pattern and a filled specimen.
- Tech Transfer & NPI →Technology Transfer Report
A plug-and-play technology transfer summary report that closes the loop: what was compared, what met acceptance criteria, deviations and how they were resolved, and a documented transfer-complete decision, with a filled specimen.
- Drug Product →Temperature Excursion Investigation Report
A plug-and-play investigation report for a cold chain temperature excursion: excursion characterization, mean kinetic temperature evaluation, root cause analysis, disposition decision, and corrective action, with a filled specimen.
- Process Validation →Validation Master Plan Gap Assessment Report
A plug-and-play report for assessing whether an existing Validation Master Plan, or the absence of one, actually describes the program as it runs today: methodology, findings table with severity classification, remediation plan, and a filled specimen.
Record 2
- CDMO Governance →CAPA Effectiveness Verification Record
A plug-and-play completed-record structure for documenting whether a CDMO's corrective action actually stopped a failure mode from recurring: the metric, the observation window, the accountable owner, the result, and a filled specimen.
- Process Validation →PPQ Personnel and Training Qualification Verification Record
A plug-and-play completed-record structure confirming every operator and analyst scheduled on PPQ batches holds a dated training record for the exact approved batch record version, not just the general unit operation, with a filled specimen.
No documents match that filter. Clear it to see the full library.